EXAS logo

Exact Sciences Corporation (EXAS) EBITDA

Annual EBITDA:

$23.07M+$99.43M(+130.21%)
December 31, 2024

Summary

  • As of today, EXAS annual EBITDA is $23.07 million, with the most recent change of +$99.43 million (+130.21%) on December 31, 2024.
  • During the last 3 years, EXAS annual EBITDA has risen by +$546.11 million (+104.41%).
  • EXAS annual EBITDA is now at all-time high.

Performance

EXAS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASincome statement metrics

Quarterly EBITDA:

$58.05M+$102.03M(+231.97%)
June 30, 2025

Summary

  • As of today, EXAS quarterly EBITDA is $58.05 million, with the most recent change of +$102.03 million (+231.97%) on June 30, 2025.
  • Over the past year, EXAS quarterly EBITDA has increased by +$26.95 million (+86.68%).
  • EXAS quarterly EBITDA is now at all-time high.

Performance

EXAS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASincome statement metrics

TTM EBITDA:

$51.09M+$26.95M(+111.66%)
June 30, 2025

Summary

  • As of today, EXAS TTM EBITDA is $51.09 million, with the most recent change of +$26.95 million (+111.66%) on June 30, 2025.
  • Over the past year, EXAS TTM EBITDA has increased by +$111.67 million (+184.34%).
  • EXAS TTM EBITDA is now at all-time high.

Performance

EXAS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

EXAS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+130.2%+86.7%+184.3%
3Y3 Years+104.4%+187.8%+110.8%
5Y5 Years+120.0%+225.9%+211.6%

EXAS EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+104.4%at high+184.1%at high+111.2%
5Y5-Yearat high+104.4%at high+124.1%at high+109.0%
All-TimeAll-Timeat high+104.4%at high+124.1%at high+109.0%

EXAS EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$58.05M(+232.0%)
$51.09M(+111.7%)
Mar 2025
-
-$43.98M(-486.7%)
$24.14M(+66.6%)
Dec 2024
$23.07M(+130.2%)
$11.37M(-55.7%)
$14.48M(+166.0%)
Sep 2024
-
$25.66M(-17.5%)
-$21.95M(+63.8%)
Jun 2024
-
$31.09M(+158.0%)
-$60.58M(+45.2%)
Mar 2024
-
-$53.64M(-114.0%)
-$110.64M(-42.8%)
Dec 2023
-$76.36M(+80.7%)
-$25.06M(-93.2%)
-$77.47M(+31.6%)
Sep 2023
-
-$12.97M(+31.6%)
-$113.19M(+33.1%)
Jun 2023
-
-$18.97M(+7.4%)
-$169.25M(+21.8%)
Mar 2023
-
-$20.47M(+66.3%)
-$216.40M(+37.2%)
Dec 2022
-$394.72M(+24.5%)
-$60.78M(+11.9%)
-$344.58M(+24.2%)
Sep 2022
-
-$69.03M(-4.4%)
-$454.58M(+3.9%)
Jun 2022
-
-$66.12M(+55.5%)
-$472.83M(+1.0%)
Mar 2022
-
-$148.66M(+13.0%)
-$477.45M(+16.2%)
Dec 2021
-$523.04M(-2511.8%)
-$170.77M(-95.7%)
-$569.60M(-59.7%)
Sep 2021
-
-$87.28M(-23.4%)
-$356.74M(-65.3%)
Jun 2021
-
-$70.74M(+70.6%)
-$215.82M(-12.9%)
Mar 2021
-
-$240.80M(-672.2%)
-$191.19M(-2023.2%)
Dec 2020
$21.69M(+118.8%)
$42.09M(-21.5%)
$9.94M(+121.7%)
Sep 2020
-
$53.64M(+216.3%)
-$45.77M(+63.4%)
Jun 2020
-
-$46.11M(-16.2%)
-$125.06M(-20.2%)
Mar 2020
-
-$39.67M(-191.1%)
-$104.08M(+16.4%)
Dec 2019
-$115.31M(+15.5%)
-$13.63M(+46.9%)
-$124.47M(+18.8%)
Sep 2019
-
-$25.65M(-2.0%)
-$153.27M(+5.6%)
Jun 2019
-
-$25.14M(+58.1%)
-$162.39M(+1.5%)
Mar 2019
-
-$60.06M(-41.6%)
-$164.81M(-20.8%)
Dec 2018
-$136.39M(-32.7%)
-$42.43M(-22.0%)
-$136.39M(-21.1%)
Sep 2018
-
-$34.77M(-26.1%)
-$112.64M(-10.2%)
Jun 2018
-
-$27.56M(+12.9%)
-$102.22M(+0.1%)
Mar 2018
-
-$31.64M(-69.3%)
-$102.33M(+0.5%)
Dec 2017
-$102.75M(+34.8%)
-$18.68M(+23.2%)
-$102.89M(+13.4%)
Sep 2017
-
-$24.34M(+12.0%)
-$118.84M(+8.4%)
Jun 2017
-
-$27.67M(+14.1%)
-$129.74M(+10.1%)
Mar 2017
-
-$32.19M(+7.1%)
-$144.34M(+8.4%)
Dec 2016
-$157.51M(-4.1%)
-$34.64M(+1.7%)
-$157.51M(+2.2%)
Sep 2016
-
-$35.24M(+16.6%)
-$161.10M(+3.6%)
Jun 2016
-
-$42.27M(+6.8%)
-$167.20M(-2.9%)
Mar 2016
-
-$45.36M(-18.6%)
-$162.50M(-7.2%)
Dec 2015
-$151.32M(-56.3%)
-$38.23M(+7.5%)
-$151.57M(-4.9%)
Sep 2015
-
-$41.34M(-10.0%)
-$144.47M(-7.5%)
Jun 2015
-
-$37.58M(-9.2%)
-$134.43M(-16.2%)
Mar 2015
-
-$34.42M(-10.6%)
-$115.73M(-19.5%)
Dec 2014
-$96.83M(-113.5%)
-$31.14M(+0.5%)
-$96.83M(-24.9%)
Sep 2014
-
-$31.29M(-65.7%)
-$77.52M(-35.6%)
Jun 2014
-
-$18.88M(-21.6%)
-$57.15M(-13.6%)
Mar 2014
-
-$15.52M(-31.3%)
-$50.28M(-10.9%)
Dec 2013
-$45.34M(+12.2%)
-$11.82M(-8.3%)
-$45.34M(+4.0%)
Sep 2013
-
-$10.92M(+9.2%)
-$47.24M(+3.8%)
Jun 2013
-
-$12.02M(-13.6%)
-$49.08M(+5.1%)
Mar 2013
-
-$10.58M(+22.9%)
-$51.74M(-0.2%)
Dec 2012
-$51.66M
-$13.72M(-7.6%)
-$51.66M(-22.4%)
Sep 2012
-
-$12.76M(+13.1%)
-$42.20M(-13.5%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$14.68M(-39.8%)
-$37.16M(-27.9%)
Mar 2012
-
-$10.50M(-146.2%)
-$29.05M(-26.9%)
Dec 2011
-$28.42M(-145.1%)
-$4.26M(+44.8%)
-$22.89M(-2.3%)
Sep 2011
-
-$7.73M(-17.7%)
-$22.39M(-24.4%)
Jun 2011
-
-$6.56M(-51.4%)
-$17.99M(-29.9%)
Mar 2011
-
-$4.33M(-15.3%)
-$13.86M(-19.5%)
Dec 2010
-$11.60M(-40.1%)
-$3.76M(-12.8%)
-$11.60M(-20.6%)
Sep 2010
-
-$3.33M(-37.4%)
-$9.62M(-31.0%)
Jun 2010
-
-$2.43M(-17.0%)
-$7.34M(+0.0%)
Mar 2010
-
-$2.08M(-16.6%)
-$7.34M(+18.7%)
Dec 2009
-$8.28M(+5.4%)
-$1.78M(-68.2%)
-$9.04M(+1.5%)
Sep 2009
-
-$1.06M(+56.4%)
-$9.17M(+13.2%)
Jun 2009
-
-$2.43M(+35.6%)
-$10.56M(-6.0%)
Mar 2009
-
-$3.77M(-96.8%)
-$9.96M(-13.9%)
Dec 2008
-$8.74M(+20.9%)
-$1.92M(+21.8%)
-$8.74M(+17.4%)
Sep 2008
-
-$2.45M(-33.7%)
-$10.58M(+8.6%)
Jun 2008
-
-$1.83M(+28.2%)
-$11.58M(+1.0%)
Mar 2008
-
-$2.55M(+32.0%)
-$11.69M(-5.7%)
Dec 2007
-$11.06M(+11.2%)
-$3.75M(-9.1%)
-$11.06M(-21.0%)
Sep 2007
-
-$3.44M(-77.1%)
-$9.14M(-5.2%)
Jun 2007
-
-$1.94M(-1.3%)
-$8.69M(+12.3%)
Mar 2007
-
-$1.92M(-4.5%)
-$9.90M(+18.3%)
Dec 2006
-$12.45M(+9.1%)
-$1.84M(+38.5%)
-$12.13M(+6.1%)
Sep 2006
-
-$2.99M(+5.5%)
-$12.91M(+1.2%)
Jun 2006
-
-$3.16M(+23.7%)
-$13.06M(+5.1%)
Mar 2006
-
-$4.14M(-58.1%)
-$13.76M(-2.1%)
Dec 2005
-$13.70M(+21.6%)
-$2.62M(+16.6%)
-$13.48M(+11.3%)
Sep 2005
-
-$3.14M(+18.6%)
-$15.19M(+6.3%)
Jun 2005
-
-$3.86M(-0.0%)
-$16.20M(+1.1%)
Mar 2005
-
-$3.86M(+10.9%)
-$16.38M(+6.2%)
Dec 2004
-$17.47M(+32.9%)
-$4.33M(-4.0%)
-$17.47M(+4.8%)
Sep 2004
-
-$4.16M(-3.0%)
-$18.34M(+9.6%)
Jun 2004
-
-$4.04M(+18.3%)
-$20.29M(+13.7%)
Mar 2004
-
-$4.94M(+5.0%)
-$23.50M(+9.7%)
Dec 2003
-$26.03M(+9.3%)
-$5.20M(+14.9%)
-$26.03M(+4.9%)
Sep 2003
-
-$6.11M(+15.7%)
-$27.38M(+3.4%)
Jun 2003
-
-$7.25M(+2.9%)
-$28.34M(+1.4%)
Mar 2003
-
-$7.46M(-13.9%)
-$28.74M(-0.2%)
Dec 2002
-$28.69M(-14.4%)
-$6.55M(+7.4%)
-$28.69M(-0.9%)
Sep 2002
-
-$7.07M(+7.5%)
-$28.44M(-3.8%)
Jun 2002
-
-$7.65M(-3.2%)
-$27.39M(-5.2%)
Mar 2002
-
-$7.41M(-17.6%)
-$26.04M(-5.8%)
Dec 2001
-$25.08M(-94.0%)
-$6.30M(-4.5%)
-$24.62M(-3.6%)
Sep 2001
-
-$6.03M(+4.3%)
-$23.76M(-34.0%)
Jun 2001
-
-$6.30M(-5.2%)
-$17.73M(-55.1%)
Mar 2001
-
-$5.99M(-10.0%)
-$11.43M(-114.0%)
Dec 2000
-$12.93M(-167.1%)
-
-
Dec 2000
-
-$5.44M(-5506.0%)
-$5.34M(-5406.0%)
Mar 2000
-
$100.70K
$100.70K
Dec 1999
-$4.84M(-28.1%)
-
-
Dec 1998
-$3.78M(-96.5%)
-
-
Dec 1997
-$1.92M
-
-

FAQ

  • What is Exact Sciences Corporation annual EBITDA?
  • What is the all-time high annual EBITDA for Exact Sciences Corporation?
  • What is Exact Sciences Corporation annual EBITDA year-on-year change?
  • What is Exact Sciences Corporation quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Exact Sciences Corporation?
  • What is Exact Sciences Corporation quarterly EBITDA year-on-year change?
  • What is Exact Sciences Corporation TTM EBITDA?
  • What is the all-time high TTM EBITDA for Exact Sciences Corporation?
  • What is Exact Sciences Corporation TTM EBITDA year-on-year change?

What is Exact Sciences Corporation annual EBITDA?

The current annual EBITDA of EXAS is $23.07M

What is the all-time high annual EBITDA for Exact Sciences Corporation?

Exact Sciences Corporation all-time high annual EBITDA is $23.07M

What is Exact Sciences Corporation annual EBITDA year-on-year change?

Over the past year, EXAS annual EBITDA has changed by +$99.43M (+130.21%)

What is Exact Sciences Corporation quarterly EBITDA?

The current quarterly EBITDA of EXAS is $58.05M

What is the all-time high quarterly EBITDA for Exact Sciences Corporation?

Exact Sciences Corporation all-time high quarterly EBITDA is $58.05M

What is Exact Sciences Corporation quarterly EBITDA year-on-year change?

Over the past year, EXAS quarterly EBITDA has changed by +$26.95M (+86.68%)

What is Exact Sciences Corporation TTM EBITDA?

The current TTM EBITDA of EXAS is $51.09M

What is the all-time high TTM EBITDA for Exact Sciences Corporation?

Exact Sciences Corporation all-time high TTM EBITDA is $51.09M

What is Exact Sciences Corporation TTM EBITDA year-on-year change?

Over the past year, EXAS TTM EBITDA has changed by +$111.67M (+184.34%)
On this page